½ÃÀ庸°í¼­
»óǰÄÚµå
1496013

¼¼°èÀÇ ÀÇ·á¿ë ħ´ë ½ÃÀå : ¿¹Ãø(2024-2029³â)

Global Medical Bed Market - Forecasts from 2024 to 2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 103 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ħ´ë(Medical Bed) ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È CAGR 5.14%·Î ÃßÀÌÇÏ¸ç ¼ºÀå ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³â 34¾ï 7,400¸¸ ´Þ·¯¿¡¼­ 2029³â¿¡´Â 49¾ï 2,500¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á¿ë ħ´ë »ê¾÷Àº ÀϹÝÀûÀÎ ÀÇ·á¿ë ħ´ë, »ê°ú¿ë ħ´ë, ¼Ò¾Æ¿ë ħ´ë, üÁß °¨¼Ò ħ´ë, ºñ¸¸¿ë ħ´ë µî °Ç°­ °ü¸® ȯ°æÀ» À§ÇØ °³·«µÈ ´Ù¾çÇÑ À¯ÇüÀÇ Ä§´ë·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ½ÃÀåÀº °í·ÉÈ­ Àα¸ Áõ°¡, ³­Ä¡º´ÀÇ ¿ì¼¼, Çõ½ÅÀûÀÎ ±â¼úÀÇ Áøº¸, ±¹³» °Ç°­ °ü¸® ÆÐÅÏ¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ÀÏ¹Ý ÀÇ·á¿ë ħ´ë´Â Áø·á¼Ò³ª º´¿ø¿¡¼­ ȯÀÚÀÇ Äɾî, ¿ä¾ç, Ä¡·á óġ¿¡ ÀÌ¿ëµË´Ï´Ù.

°¡Á¤¿ë ħ´ë´Â ÇÕ¹ýÀûÀÎ À¯Áö º¸¼ö°¡ ºÒ°¡´ÉÇϱ⠶§¹®¿¡ Ä¡·á ħ´ë´Â ¿À¿° ¹æÁö, û°á ¹× À§»ý °ü¸®°¡ ÇÊ¿äÇÑ È¯ÀÚ¸¦ À§ÇØ ¸¸µé¾îÁý´Ï´Ù. °Ô´Ù°¡, ÀÇ·á¿ë ħ´ë´Â ü°Ý¿¡ À¶Å뼺ÀÌ ÀÖ¾î, ȯÀÚ°¡ Ä¡·á¸¦ ¹ÞÀ» ¶§ÀÇ ÄèÀû¼ºÀ̳ª Æí¸®¼º µî, ´Ù¾çÇÑ Æ¯ÀüÀÌ ÀÖ½À´Ï´Ù. Ä¡·á ³»¿ë¿¡ µû¶ó ÀÇ·á¿ë ħ´ë´Â ´Ù¾çÇÑ È¯ÀÚ¿¡°Ô ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

±¹³» °Ç°­ °ü¸®´Â ¸¸¼º Áúȯ ȯÀÚ ¹× ¼ö¼ú ÈÄ È¸º¹±â¿¡ Àִ ȯÀÚ¸¦ ¼ö¿ëÇÏ¿© ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. Àå±â ¿ä¾ç ½Ã¼³¿¡¼­´Â ´Ù¾çÇÑ ÀÇ·á¿ë ħ´ë°¡ ÇÊ¿äÇÏ¸ç ´Ù¾çÇÑ Áֹε鿡°Ô ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ±âÁ¸ ±â¾÷°ú ½ÅÈï ±â¾÷ ¸ðµÎ Áö¼ÓÀûÀÎ ÄèÀû¼º°ú ¼÷·Ãµµ¸¦ Çâ»ó½Ã۱â À§ÇÑ Áøº¸¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Á¦Ç°ÀÇ ¾ÈÀü°ú ǰÁúÀ» º¸ÀåÇϱâ À§Çؼ­´Â ÇàÁ¤ ¹× ÀÎÁõ Áؼö°¡ ÇʼöÀûÀÔ´Ï´Ù.

ȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á¿ë ħ´ë´Â °£º´Àο¡°Ôµµ ÀÌ»óÀûÀÎ À§»ý ȯ°æ°ú û°áÀ» À¯ÁöÇÒ ¼ö ÀÖ´Ù´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ħ´ëÀÇ ¼ö´Â Ä¡À¯ ¼¾ÅÍ ¹× º´¿ø ÇÁ·¹ÀÓ ¿öÅ©ÀÇ ¿ë·®°ú °ßÀûÀ» °áÁ¤ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

  • ¸¸¼º ÁúȯÀÇ À¯ÇàÀº ÀÇ·á¿ë ħ´ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º´»óÀÇ °¡Àå Å« ¼ºÀå ¿äÀÎ Áß Çϳª´Â Àα¸ÀÇ ³ëÈ­ÀÔ´Ï´Ù. À¯¿£¿¡ µû¸£¸é ¼¼°èÀÇ 65¼¼ ÀÌ»óÀÇ Àα¸´Â ±Þ¼ÓÈ÷ Áõ°¡Çϰí ÀÖÀ¸¸ç, ±× ºñÀ²Àº 2022³âÀÇ 10%¿¡¼­ 2050³â¿¡´Â 16%·Î »ó½ÂÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. 2050³â±îÁö´Â 65¼¼ ÀÌ»óÀÇ Àα¸´Â 5¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ ¼öÀÇ 2¹è, 12¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ ¼ö¿Í °ÅÀÇ µ¿ÀÏÇÏ´Ù°í ÇÕ´Ï´Ù. °Ô´Ù°¡ ³ëÀÎ Àα¸ Áõ°¡¿Í ´õ ³ªÀº Ä¡·á¿Í ÆíÀǸ¦ À§ÇØ ÀÇ·á¿ë ħ´ë¸¦ »ç¿ëÇØ¾ß ÇÏ´Â »ýȰ ½À°üº´Àº ¿¹Ãø ±â°£ µ¿¾È »ê¾÷ È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àα¸°¡ °í·ÉÈ­µÊ¿¡ µû¶ó ¸¸¼º Áúȯ°ú °ü·Ã ÀÔ¿øÀÌ ÈçÇØÁö°í º´»ó ¼ö¿ä°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. National Center for Chronic Disease Prevention and Health Promotion(±¹¸³ ¸¸¼º Áúȯ ¿¹¹æ ¹× °Ç°­ ÁõÁø ¼¾ÅÍ)¿¡ µû¸£¸é 2023³â 3¿ù ÇöÀç ¸¸¼º Áúȯ°ú Á¤½Å ÁúȯÀÇ ¿¬°£ ÀÇ·áºñ´Â 4Á¶ 1,000¾ï ´Þ·¯¿¡ À̸¨´Ï´Ù. »çȸ°æÁ¦¿Í Áúº´ ÆÐÅÏÀÇ º¯È­, °Ç°­ °ü¸® ÇàÁ¤ ¹× °ü·Ã ¼­ºñ½º¿¡ ´ëÇÑ ¾Ð·Â Áõ°¡·Î ÀÇ·á¿ë º´»ó ¼ö¿ä°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

  • ±â¼úÀÇ Áøº¸°¡ ÀÇ·á¿ë ħ´ë ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇコÄÉ¾î ºÎ¹®ÀÌ ¼¼°è¿¡¼­ ¹ßÀü¡¤È®´ëµÊ¿¡ µû¶ó ÀÇ·á¿ë ħ´ë¿¡ ´ëÇÑ ¿ä±¸µµ È®´ëµÉ °ÍÀÔ´Ï´Ù. Çõ½ÅÀûÀÎ ±â¼ú Áøº¸, ÇコÄÉ¾î ±â¹ÝÀÇ Áøº¸, °³¹ßµµ»ó±¹ÀÇ ÇコÄÉ¾î ºÎ¹®¿¡¼­ ¿¬±¸°³¹ß Áõ°¡¿¡ ÀÇÇØ ÀÇ·á¿ë ħ´ë »ê¾÷ Áõ°¡À²Àº °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ¼ö½Ê ³â°£ Ä¡·á ¸ñÀû¿¡ ƯȭµÈ Ä¡·á±â±¸°¡ Àα⸦ ¾ò°í ÀÖÀ¸¸ç, ÀÌ È帧Àº ÀÇ·á ħ´ë ¾÷°è¿¡¼­µµ ¸¶Âù°¡Áö·Î ½ÇÇàµÇ°í ÀÖ½À´Ï´Ù.

¿¹»óµÇ´Â ±â°£ µ¿¾È ÀÌ ¾÷°è¿¡¼­´Â Ư¼ö ÀÇ·á¿ë ħ´ë Áõ°¡°¡ ¿¹»óµË´Ï´Ù. Á¤ºÎÀÇ °Ç°­ °ü¸®¿¡ ´ëÇÑ °Å´ëÇÑ ÅõÀÚ´Â ½ÃÀå °³Ã´¿¡ º¯È­¸¦ ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 6¿ù IFC´Â ÀÌÁýÆ® ÀÇ·á ¼­ºñ½º(Egyptians for Health Care Services)¿Í Á¦ÈÞÇÏ¿© Ä«ÀÌ·Î ±³¿Ü¿¡ ÀÇ·á ÇãºêÀÎ CapitalMed¸¦ °³¹ßÇß½À´Ï´Ù. ÀÌ Çãºê´Â ÀÌÁýÆ®ÀÇ ÇコÄÉ¾î ½Ã½ºÅÛÀ» °­È­ÇÏ´Â °ÍÀ¸·Î Á¾ÇÕº´¿ø À̿ܿ¡ 19°³ Àü¹®±â°üÀÌ µé¾î°¥ ¿¹Á¤À̾ú½À´Ï´Ù. ¿Ü·¡È¯Àڽü³, °¡»óÄɾ¿ø, 300Ãþ ÀÌ»óÀÇ ´Ù°ú¸ñº´¿øÀº ¸ðµÎ 2023³â °³¿ø ¿¹Á¤ÀÇ Á¦1±âÀÇ ÀϺÎÀÔ´Ï´Ù. ¶ÇÇÑ ¼¾ÅÍ ¿Ï¼º ½Ã¿¡´Â 70°³ÀÇ ¼ö¼ú½Ç, 700°³ÀÇ ±Þ¼º±â Ä¡·á À¯´Ö, ¾à 4,000°³ÀÇ Ä§´ë¸¦ °®Ãß°í ÀÖ¾ú½À´Ï´Ù.

°Ô´Ù°¡ Àü¹®±â¼úÀÇ Áøº¸, Ä¡·á¿ë º´»óÀÇ ¼±ÅÃ, º´¿ø¼ö Áõ°¡°¡ ¿¹Ãø±â°£À» ÅëÇØ ¾÷°è È®´ë¸¦ ÃËÁøÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¾î·µç ÀÇ·á ħ´ë ¼ö¿Í °³¾÷ Ŭ¸®´Ð ħ´ë ¼öÀÇ °¨¼Ò´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ½ÃÀåÀÌ ½ÃÀå Á¡À¯À²À» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ½ÃÀå È®´ë´Â ÀÌ Áö¿ªÀÇ ÇコÄÉ¾î ±â¹ÝÀÇ È®¸³, ´ç´¢º´ Àα¸ Áõ°¡, ÀÇ·á ħ´ë ½ÃÀåÀÇ °æÀï»ç°¡ ±Ùó¿¡ Á¸ÀçÇÏ´Â µî¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ¾ÏÀ̳ª ±âŸ Áö¼Ó¼º °¨¿°ÀÇ Àç¹ßÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Medicare & Medicaid Service CenterÀÇ NHE Fact Sheet¿¡ µû¸£¸é 2022³â ±¹¹Î°Ç°­º¸Çè(NHI)Àº 4.1% Áõ°¡ÇÑ 4Á¶ 5,000¾ï ´Þ·¯, ¹Ì±¹ GDPÀÇ 17.3%¿¡ ´ÞÇß½À´Ï´Ù. ¸ÞµðÄÉÀ̵å ÁöÃâÀº 9.6% Áõ°¡ÇÑ 8,057¾ï ´Þ·¯, ¸ÞµðÄɾî ÁöÃâÀº 5.9% Áõ°¡ÇÑ 9,443¾ï ´Þ·¯·Î ±ÞÁõÇß½À´Ï´Ù. ¹Î°£ÀǷẸÇè¿¡ ´ëÇÑ ÁöÃâÀº 5.9% Áõ°¡ÇÑ 1Á¶ 2,898¾ï ´Þ·¯¿´½À´Ï´Ù.

1Àδç ÇコÄɾî ÅõÀÚ Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ¸¸¼ºÁúȯ Àç¹ß Áõ°¡, Áö¿ª ³» Çõ½ÅÀûÀÎ º¯È­·Î ÀÎÇØ ºÏ¹Ì´Â ¿¹»ó±â°£ µ¿¾È ´õ¿í ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¢±¹¿¡¼­ µµÀԵǰí ÀÖ´Â ÀÇ·á¿ë º´»ó¼ö Áõ°¡°¡ ºÏ¹ÌÀÇ ÀÇ·á¿ë ħ´ë ½ÃÀå È®´ëÀÇ ±ØÈ÷ Áß¿äÇÑ ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ¹ßÀü

  • 2023³â 6¿ù-LINET ±×·ìÀº ¼¼°è °£È£ Á÷¿ø ºÎÁ·¿¡ ´ëÀÀÇϱâ À§ÇØ ¸¸´É °£È£ º´¿ø ħ´ë 'ESSENZA 300'À» ¹ßÇ¥Çß½À´Ï´Ù. LINETÀÇ ÆÄÆ®³ÊÀÎ SUSPA´Â ½Â°­, °æ»ç, °¨¼èÀÇ ÀÇ·á ±â¼ú ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Á¦Ç°Àº °¡½º ½ºÇÁ¸µ, ´ïÆÛ ¹× ³ôÀÌ Á¶Àý ½Ã½ºÅÛÀ» ÅëÇØ °£È£ È¿À²°ú ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãŵ´Ï´Ù. ESSENZA 300Àº º´¿ø ħ´ëÀÇ ´ÙÀ½ ´Ü°è·Î, °£º´ÀÎÀÇ ÀÏ»ó ¾÷¹«¸¦ ´ú¾îÁÖ°í Æ¯È÷ Áúº´À̳ª ¾à¹°À» º¹¿ëÇϴ ȯÀÚÀÇ ³«»óÀ» ¿¹¹æÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • 2023³â 6¿ù-Baxter InternationalÀº ¹Ì±¹¿¡¼­ º¹ÀâÇÑ Ä¡¸íÀûÀÎ Ä¡·á ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ °í¾ÈµÈ ICU º£µå Hillrom Progressa¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Ä§´ë´Â °£È£»ç°¡ ȯÀÚ¸¦ ½±°Ô Ä¡·áÇϰí ȸº¹À» Áö¿øÇÏ´Â »õ·Î¿î ±â¼ú°ú ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ Ä§´ë´Â Æó ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ Ä§´ë¿¡¼­ ŸÁø, Áøµ¿, Áö¼ÓÀûÀÎ Ãø¸é ȸÀü ¿ä¹ý, ÇǺΠº¸È£ ¹× »óó Ä¡À¯¸¦ À§ÇÑ °­È­ µÈÁöÁö Ç¥¸é, ¼¼Ã´À» ¿ëÀÌÇÏ°Ô Çϱâ À§ÇØ »õ·Î¿î »ó´Ü Ä¿¹ö°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
  • 2023³â 3¿ù-Å×Çì¶õ¿¡ Áßµ¿ ÃÖ´ëÀÇ 1,000¸¶·ç¸¦ µÐ ¸¶Çϵð Ŭ¸®´Ð º´¿øÀÌ °³¿øÇß½À´Ï´Ù. 108,000Á¦°ö¹ÌÅÍ, 18ÃþÂ¥¸® ÀÌ º´¿øÀº Å×Çì¶õ ½Ã³»¿¡ À§Ä¡ÇØ ¿Ü·¡ ȯÀÚ 42¸í, ÀÀ±Þ ȯÀÚ 110¸í, ÁßÁõ ȯÀÚ 204¸íÀ» ¼ö¿ëÇÕ´Ï´Ù. À̶õ ÃÖ´ëÀÇ °Ç°­ °ü¸® ÇÁ·ÎÁ§Æ®·Î 380¸íÀÇ ÀÇ»ç¿Í ÀÇÇÐ ±³¼ö°¡ »óÁÖÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­
  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ ¹× ¿¹Ãø¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ °ü°èÀÚÀÇ ÁÖ¿ä ÀÌÁ¡

Á¦2Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¼³°è
  • Á¶»ç °úÁ¤

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä Á¶»ç °á°ú

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ

Á¦5Àå ÀÇ·á¿ë ħ´ë ½ÃÀå : À¯Çüº°

  • ¼Ò°³
  • ¼öµ¿
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ¹ÝÀüµ¿
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ÀüÀüµ¿
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • Ư¼ö º´¿ø¿ë ħ´ë
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº

Á¦6Àå ÀÇ·á¿ë ħ´ë ½ÃÀå : »ç¿ëº°

  • ¼Ò°³
  • Àå±â Äɾî
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ±Þ¼º±â Äɾî
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • Ãâ»ê
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ±âŸ
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº

Á¦7Àå ÀÇ·á¿ë ħ´ë ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ºñÁýÁßÄ¡·á
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ÁýÁßÄ¡·á
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº

Á¦8Àå ÀÇ·á¿ë ħ´ë ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • º´¿ø
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ÀçÅà Äɾî
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº
  • ±âŸ
    • ½ÃÀå ±âȸ ¹× µ¿Çâ
    • ¼ºÀå Àü¸Á
    • Áö¸®Àû ÀÌÀͼº

Á¦9Àå ÀÇ·á¿ë ħ´ë ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • À¯Çüº°
    • »ç¿ëº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • ³²¹Ì
    • À¯Çüº°
    • »ç¿ëº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • À¯·´
    • À¯Çüº°
    • »ç¿ëº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • À¯Çüº°
    • »ç¿ëº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç
    • À¯Çüº°
    • »ç¿ëº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°

Á¦10Àå °æÀï ȯ°æ ¹× ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ ¹× Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Hill-Rom Services Inc.
  • Stryker Corporation
  • Invacare Corporation
  • PARAMOUNT BED CO., LTD.
  • Medline Industries, Inc.
  • Joh. Stiegelmeyer GmbH & Co. KG
  • Gendron Inc.
  • ARJO
  • Joerns Healthcare LLC.
  • Linet
LYJ

The global medical bed market is projected to grow at a CAGR of 5.14% during the forecast period to reach US$4.925 billion by 2029, up from US$3.474 billion in 2022.

The medical bed industry comprises different sorts of beds outlined for healthcare settings, like common medical beds, maternity beds, pediatric beds, weight relief beds, and bariatric beds. The market is driven by the increasing aging populace, the predominance of persistent illnesses, innovative technological progressions, and domestic healthcare patterns. General medical beds are utilized in clinics and hospitals for the care of patients, recuperation, and therapeutic procedures.

Since household beds are not legitimately maintained, therapeutic beds are built for patients who require great contamination control, cleanliness, and hygiene. In addition, medical beds are flexible in stature and allow an assortment of benefits to patients, including comfort and convenience as patients are getting treatment. Depending on the treatment, medical beds can be customized for a different of patients.

Domestic healthcare is picking up notoriety, catering to patients with chronic sicknesses, or recouping from surgeries. Long-term care facilities need an assortment of medical beds and oblige diverse inhabitants. The market is competitive, with established companies and rising players centering on advancement to upgrade persistent comfort and proficiency. Compliance with administrative measures and certifications is vital for producers and providers to guarantee product security and quality.

Diverse locales may have particular controls in administering the plan and fabricating of medical beds.Besides patients, clinic beds can advantage caregivers by permitting them to preserve ideal sanitation and cleanliness. The number of medical beds is utilized to decide the capacity and estimate of a healing center or hospital framework.

Market Drivers:

  • The prevalence of chronic diseases is predicted to increase the demand for medical beds.

One of the biggest growth drivers for hospital beds is the aging population. According to the United Nations, the global population of individuals aged 65 and above is rapidly increasing, with the percentage expected to rise from 10% in 2022 to 16% in 2050. By 2050, the number of individuals aged 65 or above will be twice the number of children under 5 and almost equivalent to the number of children under 12 years. Moreover, the growing elderly populace and lifestyle-caused disorders that require the utilization of medical beds for way better treatment and convenience are anticipated to drive industry extension over the projected period.

With the growing aging population, chronic illnesses and their related hospitalizations are becoming more common, expanding the demand for hospital beds. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic disease, and mental health conditions fetched $4.1 trillion in yearly healthcare costs as of March 2023. Demand for medical beds is anticipated to extend as a result of changing socioeconomics and illness patterns, as well as the increased pressure on healthcare administrations and related services.

  • Technological advancement is expected to fuel the global medical bed market growth.

The requirement for medical beds is bound to extend as the healthcare division develops and extends around the world. The rate of increase in the medical bed industry has quickened because of innovative technological advancements, progressed healthcare foundations, and increasing research and development within the healthcare division in developing nations. Therapeutic equipment that's specialized and especially employed for a therapeutic reason has gained popularity in recent decades, and this drift is being executed within the medical bed trade as well.

Over the anticipated period, the industry is anticipated to see an increase in the advancement of specialized medical beds. The government's gigantic investment in healthcare is additionally making a difference in the market's development. For instance, in June 2022, IFC partnered with Egyptians for Health Care Services to develop CapitalMed, a medical hub on the outskirts of Cairo. The hub enhanced Egypt's healthcare system and was anticipated to include 19 specialized institutes in addition to a general hospital. An outpatient facility, a virtual care hospital, and a multispecialty hospital with more than 300 beds are all part of the first phase, which was scheduled to open in 2023. The center also contained 70 operating rooms, 700 acute care units, and nearly 4,000 beds when it was finished.

Moreover, specialized technological advancements, therapeutic bed selection, and an increment in the number of hospitals are likely to drive industry expansion through the projected period. In any case, the number of medical beds, as well as the contracting number of beds in open clinics, are anticipated to obstruct the market's growth.

The North American market is anticipated to dominate the market share.

The industry expansion in North America can be credited to the region's well-established healthcare foundation, rising diabetes predominance, and the nearness of critical medical bed market competitors. In expansion, the rising recurrence of cancer and other persistent infections within the region is anticipated to drive market growth in the coming years.

The "NHE Fact Sheet" from the Centers for Medicare & Medicaid Services stated that in 2022, National Health Insurance (NHI) increased 4.1% to $4.5 trillion, or 17.3% of the US GDP. While Medicaid expenditure rose by 9.6% to $805.7 billion, Medicare spending jumped by 5.9% to $944.3 billion. Spending on private health insurance rose by 5.9% to $1,289.8 billion.

Due to rising per capita healthcare investing, a developing elderly population, rising recurrence of chronic illnesses, and innovative changes within the region, North America is additionally anticipated to develop significantly amid the estimated period. The expanding number of hospital medical beds introduced in nations has been a pivotal component in North America's expansion within the global medical bed market.

Key Developments:

  • June 2023- LINET Group introduced the ESSENZA 300 universal nursing and hospital bed to address the global nursing staff shortage. SUSPA, a LINET partner, offers medical technology solutions for lifting, lowering, tilting, and damping. These products improve care efficiency and patient comfort through gas springs, dampers, and height adjustment systems. The ESSENZA 300 is the next step in hospital beds, allowing caregivers to relieve their daily work and preventing falls, especially for patients with illness or medication.
  • June 2023- Baxter International introduced the Hillrom Progressa+ bed for the ICU in the US, designed to address complex critical care needs. The bed offers new technology and features to make it easier for nurses to care for patients and support recovery. It includes in-bed percussion, vibration, and continual lateral rotation therapies to reduce pulmonary complications, enhanced support surfaces for skin protection and wound healing, and a new top cover for easier cleaning. The bed supports early patient mobility when used with an integrated lift system, minimizing the risk of clinician injury.
  • March 2023- Tehran inaugurated the Mahdi Clinic Hospital, the largest in the Middle East, with 1,000 beds. The 108,000 square meter, 18-story hospital was located in downtown Tehran and houses 42 outpatients, 110 emergency, and 204 critical care beds. It is the largest healthcare project launched in Iran, it uses the permanent services of 380 doctors and medical professors.

Key Market Segments:

The Global Medical Bed Market is segmented and analyzed as below:

By Type

  • Manual
  • Semi-Electric
  • Full Electric
  • Specialty Hospital Beds

By Usage

  • Long term Care
  • Acute Care
  • Maternity
  • Others

By Application

  • Non-Intensive Care
  • Intensive Care

By End-User

  • Hospitals
  • Homecare
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL MEDICAL BED MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Manual
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Semi-Electric
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Full Electric
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Specialty Hospital Beds
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. GLOBAL MEDICAL BED MARKET BY USAGE

  • 6.1. Introduction
  • 6.2. Long term Care
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Acute Care
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Maternity
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. GLOBAL MEDICAL BED MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Non-Intensive Care
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Intensive Care
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. GLOBAL MEDICAL BED MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Homecare
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness
  • 8.4. Others
    • 8.4.1. Market Opportunities and Trends
    • 8.4.2. Growth Prospects
    • 8.4.3. Geographic Lucrativeness

9. GLOBAL MEDICAL BED MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type
    • 9.2.2. By Usage
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. U.S.
        • 9.2.5.1.1. Market Opportunities and Trends
        • 9.2.5.1.2. Growth Prospects
      • 9.2.5.2. Canada
        • 9.2.5.2.1. Market Opportunities and Trends
        • 9.2.5.2.2. Growth Prospects
      • 9.2.5.3. Mexico
        • 9.2.5.3.1. Market Opportunities and Trends
        • 9.2.5.3.2. Growth Prospects
  • 9.3. South America
    • 9.3.1. By Type
    • 9.3.2. By Usage
    • 9.3.3. By Application
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
        • 9.3.5.1.1. Market Opportunities and Trends
        • 9.3.5.1.2. Growth Prospects
      • 9.3.5.2. Argentina
        • 9.3.5.2.1. Market Opportunities and Trends
        • 9.3.5.2.2. Growth Prospects
      • 9.3.5.3. Others
        • 9.3.5.3.1. Market Opportunities and Trends
        • 9.3.5.3.2. Growth Prospects
  • 9.4. Europe
    • 9.4.1. By Type
    • 9.4.2. By Usage
    • 9.4.3. By Application
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
        • 9.4.5.1.1. Market Opportunities and Trends
        • 9.4.5.1.2. Growth Prospects
      • 9.4.5.2. France
        • 9.4.5.2.1. Market Opportunities and Trends
        • 9.4.5.2.2. Growth Prospects
      • 9.4.5.3. United Kingdom
        • 9.4.5.3.1. Market Opportunities and Trends
        • 9.4.5.3.2. Growth Prospects
      • 9.4.5.4. Spain
        • 9.4.5.4.1. Market Opportunities and Trends
        • 9.4.5.4.2. Growth Prospects
      • 9.4.5.5. Others
        • 9.4.5.5.1. Market Opportunities and Trends
        • 9.4.5.5.2. Growth Prospects
  • 9.5. Middle East and Africa
    • 9.5.1. By Type
    • 9.5.2. By Usage
    • 9.5.3. By Application
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
        • 9.5.5.1.1. Market Opportunities and Trends
        • 9.5.5.1.2. Growth Prospects
      • 9.5.5.2. Israel
        • 9.5.5.2.1. Market Opportunities and Trends
        • 9.5.5.2.2. Growth Prospects
      • 9.5.5.3. Others
        • 9.5.5.3.1. Market Opportunities and Trends
        • 9.5.5.3.2. Growth Prospects
  • 9.6. Asia Pacific
    • 9.6.1. By Type
    • 9.6.2. By Usage
    • 9.6.3. By Application
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
        • 9.6.5.1.1. Market Opportunities and Trends
        • 9.6.5.1.2. Growth Prospects
      • 9.6.5.2. Japan
        • 9.6.5.2.1. Market Opportunities and Trends
        • 9.6.5.2.2. Growth Prospects
      • 9.6.5.3. South Korea
        • 9.6.5.3.1. Market Opportunities and Trends
        • 9.6.5.3.2. Growth Prospects
      • 9.6.5.4. India
        • 9.6.5.4.1. Market Opportunities and Trends
        • 9.6.5.4.2. Growth Prospects
      • 9.6.5.5. Others
        • 9.6.5.5.1. Market Opportunities and Trends
        • 9.6.5.5.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Hill-Rom Services Inc.
  • 11.2. Stryker Corporation
  • 11.3. Invacare Corporation
  • 11.4. PARAMOUNT BED CO., LTD.
  • 11.5. Medline Industries, Inc.
  • 11.6. Joh. Stiegelmeyer GmbH & Co. KG
  • 11.7. Gendron Inc.
  • 11.8. ARJO
  • 11.9. Joerns Healthcare LLC.
  • 11.10. Linet
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦